Skip to main content

Table 4 Major adverse clinical events according to patient clusters

From: Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

N = 8701 Cluster 1 Cluster 2 Cluster 3 P
Cardiovascular events, n (%) 295 (8.7) 121 (4.7) 385 (14.1) < .001
All-cause death, n (%) 331 (9.8) 101 (3.9) 370 (13.6) < .001
Composite outcome, n (%) 502 (14.9) 187 (7.2) 571 (20.9) < .001
Any bleeding, n (%) 156 (4.6) 71 (2.7) 121 (4.5) < .001
Any readmission, n (%) 1264 (37.7) 940 (36.3) 1063 (39.3) .09
Any CV readmission, n (%) 816 (24.4) 592 (22.9) 694 (25.6) .06
Any AF readmission, n (%) 413 (12.3) 396 (15.3) 304 (11.2) < .001
Any CV non-AF readmission, n (%) 546 (16.3) 306 (11.8) 516 (19.1) < .001
Any non-CV readmission, n (%) 406 (12.1) 260 (10.0) 322 (11.9) .03
  1. Legend: for acronyms, please see previous tables’ legends